Eli Lilly Plant Progresses after Upper Macungie Final Land Plan Approval
Eli Lilly’s $3.5 billion Upper Macungie project advanced as the board of supervisors approved the final land development plan. The company outlined plans for about 1,200 construction workers, using rented parking and shuttle buses, and agreed to follow a traffic study while coordinating with the township if new issues arise. The plant will feature multiple security checkpoints and use natural-gas backup generators, with assembly of injectable medicines including Zepbound and clinical-stage Retatrutide on 150 acres.